Profound Medical Corp. (NASDAQ:PROF) is a commercial-stage medical technology company based in Mississauga, Ontario, advancing the standard of care for prostate cancer and BPH. Our proprietary, FDA-cleared technology, TULSA-PRO®, is the first and only AI-powered, MRI-guided, incision-free robotic ablation system for the ablation of prostate tissue. TULSA-PRO® gives physicians real-time precision and control, enabling customizable treatments that are both clinically effective and designed to preserve patients’ quality of life. Now available for maximum reimbursement. Discover the difference.
Looking for a particular Profound Medical Inc. employee's phone or email?
Profound Medical Inc. Questions
The Profound Medical Inc. annual revenue was $7.9 million in 2026.
Arun Menawat is the CEO of Profound Medical Inc..
169 people are employed at Profound Medical Inc..
Profound Medical Inc. is based in Mississauga, Ontario.
The NAICS codes for Profound Medical Inc. are [33, 334].
The SIC codes for Profound Medical Inc. are [384, 38].
Top Profound Medical Inc. Employees
-
Arun Menawat
CEO at Profound Medical Inc.
Oakville, ON, CA21 -
Mathieu Burtnyk
President at Profound Medical Inc.
Toronto, ON, CA1 -
Rashed Dewan
Chief Financial Officer at Profound Medical Inc.
Toronto, ON, CA22 -
24
-
45
-
Chris Driver
VP, Product Development at Profound Medical Inc.
Oakville, ON, CA2 -
Jacques Cornet
International Sales and Marketing Leader at Profound Medical Inc.
California, United States25
Related Companies
